Bought MATK @ 20.69

•  Martek was acquired by Netherlands-based DS in December 2010. 

Martek Biosciences Corporation (Martek) is engaged in the innovation and development of nutritional products from microbial sources, including algae, fungi and other microbes, that promote health and wellness. The Company's innovation and development is based on its technology in areas, such as microbial biology, algal genomics, fermentation and oil processing. The Company developed and commercialized life'sDHA, a vegetarian source of the omega-3 fatty acid docosahexaenoic acid (DHA), for use in infant formula, pregnancy and nursing products, foods and beverages, dietary supplements and animal feed.

Headquarters:6480 Dobbin Road Columbia, MD 21045

Web Address:http://www.martek.com

Note:  Heerlen, NL, 21 Dec 2010 07:15 CET

Netherlands-based DSM to acquire Martek to add new Nutrition growth platform

• DSM (NYSE Euronext: DSM KON) to offer US$31.50 for each share of Martek Biosciences Corporation (NASDAQ: MATK) in an all-cash transaction (through a tender offer)
• Total consideration of US$1,087 million (about €829 million)
• Offer price represents 35% premium to Martek’s closing share price on December 20, 2010
• Martek Board of Directors recommends the offer
• Acquisition adds new growth platform for natural, healthy Polyunsaturated Fatty Acids (PUFAs) nutrition ingredients (Omega-3 DHA and Omega-6 ARA)